This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Bunker J, Chang CL, Chapman N, Poulter N, Thom S, Thornton-Jones L, Sever P. True resistant hypertension following observed drug ingestion: A systematic evaluation. J Clin Hypertens. 2017; 19: 250–255.BunkerJChangCLChapmanNPoulterNThomSThornton-JonesLSeverPTrue resistant hypertension following observed drug ingestion: A systematic evaluation201719250255Search in Google Scholar
Vega J, Bisogano JD. The prevalence, incidence, prognosis, and associated conditions of resistant hypertension. Semin Nephrol. 2014; 34: 247–256.VegaJBisoganoJDThe prevalence, incidence, prognosis, and associated conditions of resistant hypertension201434247256Search in Google Scholar
Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J, Samani NJ, Gupta P, Madira W, Stanley A, et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart. 2014; 100: 855–861.TomaszewskiMWhiteCPatelPMascaNDamaniRHepworthJSamaniNJGuptaPMadiraWStanleyAHigh rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis2014100855861Search in Google Scholar
Peacock E, Krousel-Wood M. Adherence to antihypertensive therapy. Med Clin North Am. 2017; 101: 229–245.PeacockEKrousel-WoodMAdherence to antihypertensive therapy2017101229245Search in Google Scholar
Bergo KK, Larstorp AC, Hoffmann P, Hjørnholm U, Cataliotti A, Høieggen A, Rostrup M, Fadl Elmula FEM. Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension. Blood Press 2021; 30: 31–40.BergoKKLarstorpACHoffmannPHjørnholmUCataliottiAHøieggenARostrupMFadl ElmulaFEMRenal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension2021303140Search in Google Scholar
Carey RM, Calhoun JL, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, et al. Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Association. Hypertension. 2018; 72: e53–e90.CareyRMCalhounJLBakrisGLBrookRDDaughertySLDennison-HimmelfarbCREganBMFlackJMGiddingSSJuddEResistant hypertension: Detection, evaluation, and management: A scientific statement from the American Association201872e53e90Search in Google Scholar
Esler M. The sympathetic nervous system in hypertension: back to the future? Curr Hypertens Rep. 2015; 17: 11. doi: 10.1007/s11906-014-0519-8.EslerMThe sympathetic nervous system in hypertension: back to the future?2015171110.1007/s11906-014-0519-8Open DOISearch in Google Scholar
Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res. 2015; 116: 976–990.GrassiGMarkAEslerMThe sympathetic nervous system alterations in human hypertension2015116976990Search in Google Scholar
Schlainch MP, Sobotka PA, Kum H, Lambert E, Esler M. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009; 361: 932–934.SchlainchMPSobotkaPAKumHLambertEEslerMRenal sympathetic-nerve ablation for uncontrolled hypertension2009361932934Search in Google Scholar
Lohmeier TE, Hall JE. Device-based neuromodulation for resistant hypertension therapy: too early for prime time? Circ Res. 2019; 14: 1071–1093.LohmeierTEHallJEDevice-based neuromodulation for resistant hypertension therapy: too early for prime time?20191410711093Search in Google Scholar
Kalarus Z, Merkey B, Neuzil O, Grabowski M, Mitkowski P, Marinskis G, Erglis A, Kaźmierczak JTA, Pluta S, Gellér L, et al. Pacemaker-based cardiac neuromodulation therapy in patients with hypertension. A pilot study. Am Heart Association. 2021; 10, Nr 16: e020492. doi: 10.1161/JAHA.120.020492.KalarusZMerkeyBNeuzilOGrabowskiMMitkowskiPMarinskisGErglisAKaźmierczakJTAPlutaSGellérLPacemaker-based cardiac neuromodulation therapy in patients with hypertension. A pilot study20211016e02049210.1161/JAHA.120.020492Open DOISearch in Google Scholar
Esler MD. Krum H. Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet. 2010; 376: 1903–1909.EslerMDKrumHSobotkaPASchlaichMPSchmiederREBöhmMSymplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial201037619031909Search in Google Scholar
Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multi-centre safety and proof-of-principle cohort study. Lancet. 2009; 373: 1275–1281.KrumHSchlaichMWhitbournRSobotkaPASadowskiJBartusKKapelakBWaltonASievertHThambarSCatheter-based renal sympathetic denervation for resistant hypertension: a multi-centre safety and proof-of-principle cohort study200937312751281Search in Google Scholar
Bhatt D, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, et al. Controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014; 370: 1393–1401.BhattDKandzariDEO’NeillWWD’AgostinoRFlackJMKatzenBTLeonMBLiuMMauriLNegoitaMControlled trial of renal denervation for resistant hypertension201437013931401Search in Google Scholar
Mahfoud F, Schlaich MP, Lobo MD. Device therapy of hypertension. Circulation Research. 2021; 128: 1080–1099.MahfoudFSchlaichMPLoboMDDevice therapy of hypertension202112810801099Search in Google Scholar
Bohm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, et al. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension. 2015; 65: 766–774.BohmMMahfoudFUkenaCHoppeUCNarkiewiczKNegoitaMRuilopeLSchlaichMPSchmiederREWhitbournRFirst report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension201565766774Search in Google Scholar
Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, Midulla M, Mounier-Véhier C, Courand PY, Lantelme P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENER-HTN): a multicentre, open-label, randomised controlled trial. Lancet. 2015; 385: 1957–1965.AziziMSapovalMGossePMongeMBobrieGDelsartPMidullaMMounier-VéhierCCourandPYLantelmePOptimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENER-HTN): a multicentre, open-label, randomised controlled trial201538519571965Search in Google Scholar
Mahfoud F, Böhm M, Schmieder R, Narkiewicz K, Ewen S, Ruilope L, Schlaich M, Williams B, Fahy M, Mancia G. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry. Eur Heart J. 2019; 40: 3474–3482.MahfoudFBöhmMSchmiederRNarkiewiczKEwenSRuilopeLSchlaichMWilliamsBFahyMManciaGEffects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry20194034743482Search in Google Scholar
Booth LC, Nishi EE, Yao ST, Ramchandra R, Lambert GW, Schlaich MP, May CN. Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep. Hypertension. 2015; 65: 393–400.BoothLCNishiEEYaoSTRamchandraRLambertGWSchlaichMPMayCNReinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep201565393400Search in Google Scholar
Mompeo B, Marnillo E, Garcia-Touchrd A, Larkin T, Sanudo J. The gross anatomy of the renal sympathetic nerve revisited. Clin Anat. 2016; 29: 660–664.MompeoBMarnilloEGarcia-TouchrdALarkinTSanudoJThe gross anatomy of the renal sympathetic nerve revisited201629660664Search in Google Scholar
Sakakura K, Ladich E, Cheng Q, Otsuka F, Yahagi K, Fowler DR, Kolodgie FD, Virmani R, Joner M. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol. 2014; 64: 635–643.SakakuraKLadichEChengQOtsukaFYahagiKFowlerDRKolodgieFDVirmaniRJonerMAnatomic assessment of sympathetic peri-arterial renal nerves in man201464635643Search in Google Scholar
Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017; 390: 2160–2170.TownsendRRMahfoudFKandzariDEKarioKPocockSWeberMAEwenSTsioufisKTousoulisDSharpASPCatheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial201739021602170Search in Google Scholar
Kandzari DE, Bohm M, Mahfoud F, Weber A, Pocock S, Tsioufis K, Tousoulis D, Choi JW, East C, Brar S, et al. Effect of renal denervation on blood pressure of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-concept randomized trial. Lancet. 2018; 391: 2346–2355.KandzariDEBohmMMahfoudFWeberAPocockSTsioufisKTousoulisDChoiJWEastCBrarSEffect of renal denervation on blood pressure of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-concept randomized trial201839123462355Search in Google Scholar
Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet 2018; 391: 2335–2345.AziziMSchmiederREMahfoudFWeberMADaemenJDaviesJBasileJKirtaneAJWangYLoboMDEndovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial201839123352345Search in Google Scholar
Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp ASP, Schmieder RE, Wang Y, Saxena M, Lurz P, Sayer J, et al. 12 months result from the un-blinded phase of the RADIANCE-HTN SOLO Trial of ultrasound renal denervation. JACC-Cardiovasc Interv. 2020; 13: 2922–2933.AziziMDaemenJLoboMDMahfoudFSharpASPSchmiederREWangYSaxenaMLurzPSayerJ12 months result from the un-blinded phase of the RADIANCE-HTN SOLO Trial of ultrasound renal denervation20201329222933Search in Google Scholar
Chermin G, Szwarcfiter I, Scheinert A, Blessing E, Diehm N, Dens J, Walton A, Verheye S, Shetty S, Jonas M. First-in man experience with a novel catheter-based renal denervation system of ultrasonic ablation in patients with resistant hypertension. J Vasc Interv Radiol. 2018; 299: 1158–1166.CherminGSzwarcfiterIScheinertABlessingEDiehmNDensJWaltonAVerheyeSShettySJonasMFirst-in man experience with a novel catheter-based renal denervation system of ultrasonic ablation in patients with resistant hypertension201829911581166Search in Google Scholar
Schmieder RE, Ott C, Toennes SW, Bramlage P, Gertner M, Dawood O, Baumgart P, O’Brien B, Dasgupta I, Nickenig G, et al. Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV. J Hypertens. 2018 Mar; 36: 680–689. doi: 10.1097/HJH.0000000000001584. PMID: 29035942SchmiederREOttCToennesSWBramlagePGertnerMDawoodOBaumgartPO’BrienBDasguptaINickenigGPhase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV2018Mar3668068910.1097/HJH.000000000000158429035942Open DOISearch in Google Scholar
Mahfoud F, Renkin J, Sievert H, Bertog S, Ewen S, Böhm M, Lengelé JP, Wojakowski W, Schmieder R, van der Giet M, et al. Alcohol-mediated renal denervation using the peregrine system infusion catheter for treatment of hypertension. JACC. Cardiovasc Inter. 2020; 13: 471–484.MahfoudFRenkinJSievertHBertogSEwenSBöhmMLengeléJPWojakowskiWSchmiederRvan der GietMAlcohol-mediated renal denervation using the peregrine system infusion catheter for treatment of hypertension202013471484Search in Google Scholar
Haribabu S, Sharif F, Zafar H. Recent trends in renal denervation devices for resistant hypertension treatment. Irish J Med. Science. 2021; 190: 971–997.HaribabuSSharifFZafarHRecent trends in renal denervation devices for resistant hypertension treatment2021190971997Search in Google Scholar
Cheng X, Zhang D, Luo S, Qin S. Effect of catheter-based renal denervation on uncontrolled hypertension: A systematic review and meta-analysis. Mayo Clin Proc. 2019; 94: 1695–1706.ChengXZhangDLuoSQinSEffect of catheter-based renal denervation on uncontrolled hypertension: A systematic review and meta-analysis20199416951706Search in Google Scholar
Maqsood MH, Rubab K, Anwar F, Khan AMT, Maqsood MA, Farooq M, Tabaza L, Rangaswami J, Virk HUH. A systematic review of randomized controlled trials comparing renal sympathetic denervation versus sham procedure for the management of uncontrolled hypertension. J Cardiovasc Pharmacol. 2021; 77: 153–158.MaqsoodMHRubabKAnwarFKhanAMTMaqsoodMAFarooqMTabazaLRangaswamiJVirkHUHA systematic review of randomized controlled trials comparing renal sympathetic denervation versus sham procedure for the management of uncontrolled hypertension202177153158Search in Google Scholar
Ogoyama Y, Tada K, Abe M, Nanto S, Shibata H, Mukoyama M, Kai H, Arima H, Kario K. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials. Hypertens Res. 2022; 45: 210–220.OgoyamaYTadaKAbeMNantoSShibataHMukoyamaMKaiHArimaHKarioKEffects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials202245210220Search in Google Scholar
Qi XY, Cheng B, Li YL, Wang YF. Renal denervation, adjusted drugs, or combined therapy for resistant hypertension: A meta-regression. Medicine. 2016; Jul; 95: e3939. doi: 10.1097/MD.0000000000003939.QiXYChengBLiYLWangYFRenal denervation, adjusted drugs, or combined therapy for resistant hypertension: A meta-regression2016Jul95e393910.1097/MD.0000000000003939Open DOISearch in Google Scholar
Silverwath J, Marti KE, Phan MT, Re Amin H, Roman YM, Pasupuleti V, Banach M, Barboza JJ, Hernandez AV. Renal denervation for uncontrolled and resistant hypertension: Systematic review and network meta-analysis of randomized trials. J Clin Med. 2021; 10: 782. doi: 10.3390/jcm10040782.SilverwathJMartiKEPhanMTRe AminHRomanYMPasupuletiVBanachMBarbozaJJHernandezAVRenal denervation for uncontrolled and resistant hypertension: Systematic review and network meta-analysis of randomized trials20211078210.3390/jcm10040782Open DOISearch in Google Scholar
Stavropoulos K, Patoulias D, Imprialos K, Doumas M, Katsimardou A, Dimitriadis K, Tsioufis C, Papademetriou V. Efficacy and safety of renal denervation for the management of arterial hypertension: A systematic reviewed meta-analysis of randomized, sham-controlled, catheter-based trials. J Clin Hypertens. (Greenwich). 2020; 22: 572–584.StavropoulosKPatouliasDImprialosKDoumasMKatsimardouADimitriadisKTsioufisCPapademetriouVEfficacy and safety of renal denervation for the management of arterial hypertension: A systematic reviewed meta-analysis of randomized, sham-controlled, catheter-based trials202022572584Search in Google Scholar
Vogiatzakis N, Tsioufis C, Georgiopoulos G, Thomopoulos C, Dimitriadis K, Kasiakogias A, Konstantinidis D, Kalos T, Mahfoud F, Doumas M, Papademetriou V, Tousoulis D. Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis. J Hypertens. 2017; 35: 1750–1757.VogiatzakisNTsioufisCGeorgiopoulosGThomopoulosCDimitriadisKKasiakogiasAKonstantinidisDKalosTMahfoudFDoumasMPapademetriouVTousoulisDEffect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis20173517501757Search in Google Scholar
Pappaccogli M, Covella M, Berra E, Fulcheri C, Di Monaco S, Perlo E, Burrello J, Monticone S, Rossato D, Rabbia F, et al. Effectiveness of renal denervation in resistant hypertension. A meta-analysis of 11 controlled studies. Cochrane Database Syst Rev. 2017; 2017(2): CD011499. doi: 10.1002/14651858.CD011499.PappaccogliMCovellaMBerraEFulcheriCDi MonacoSPerloEBurrelloJMonticoneSRossatoDRabbiaFEffectiveness of renal denervation in resistant hypertension. A meta-analysis of 11 controlled studies201720172CD01149910.1002/14651858.CD011499Open DOISearch in Google Scholar
Chen C, Zhu XY, Li D, Zhou K, Lin Q. Clinical efficacy and safety of spironolactone in patients with resistant hypertension: A systematic review and meta-analysis. Medicine. 2020. 99: e21694. doi: 10.1097/MD.0000000000021694. PMID: 32846786.ChenCZhuXYLiDZhouKLinQClinical efficacy and safety of spironolactone in patients with resistant hypertension: A systematic review and meta-analysis202099e2169410.1097/MD.000000000002169432846786Open DOISearch in Google Scholar
Schmieder RE, Mahfoud F, Mancia G, Azizi M, Böhm M, Dimitriadis K, Kario K, Kroon AAD, Lobo M, Ott C, et al. European Society of Hypertension position paper on renal denervation 2021. J Hypertens. 2021; 39: 1733–1741.SchmiederREMahfoudFManciaGAziziMBöhmMDimitriadisKKarioKKroonAADLoboMOttCEuropean Society of Hypertension position paper on renal denervation 202120213917331741Search in Google Scholar
Baik J, Song WH, Yim D, Lee S, Yang S, Lee HY, Choi EK, Jeong CW, Park SM. Laparoscopic renal denervation system for treating resistant hypertension: overcoming limitation of catheter-based approaches. Trans Biomed Eng. 2020; 67: 3425–3437.BaikJSongWHYimDLeeSYangSLeeHYChoiEKJeongCWParkSMLaparoscopic renal denervation system for treating resistant hypertension: overcoming limitation of catheter-based approaches20206734253437Search in Google Scholar
Cai X, Yang Y, Shen Y, Wang W, Qian L, Cai J, Chi R, Fei Y, Yu S, Wei L, et al. Noninvasive stereotactic radiotherapy for renal denervation in a swine model. J Am Coll Cardiol. 2019; 74: 1697–1709.CaiXYangYShenYWangWQianLCaiJChiRFeiYYuSWeiLNoninvasive stereotactic radiotherapy for renal denervation in a swine model20197416971709Search in Google Scholar
Mahfoud F, Edelman E, Bhatt N. Stereotactic radiotherapy for renal denervation: to beam, or not to beam? J Am Cardiol. 2019; 74: 1710–1713.MahfoudFEdelmanEBhattNStereotactic radiotherapy for renal denervation: to beam, or not to beam?20197417101713Search in Google Scholar
Lohmeier TE, Iliescu R, Terry M, Dwyer M, Lohmeier TE, Iliescu R, Terry M, Dwyer TM, et al. Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex. Am J Physiol Heart Circ Physiol. 2010; 299: H402–H409.LohmeierTEIliescuRTerryMDwyerMLohmeierTEIliescuRTerryMDwyerTMSustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex2010299H402H409Search in Google Scholar
Wallbach M, Halbach M, Reuter H, Passauer J, Lüders S, Böhning E, Zenker D, Müller GA, Wachter R, Koziolek MJ. Baroreflex activation therapy in patients with prior renal denervation. J Hypertens. 2016; 34: 1630–1638.WallbachMHalbachMReuterHPassauerJLüdersSBöhningEZenkerDMüllerGAWachterRKoziolekMJBaroreflex activation therapy in patients with prior renal denervation20163416301638Search in Google Scholar
Scheffers IJ, Kroon AA, Schmidli J, Jordan J, Tordoir JJ, Mohaupt MG, Luft FC, Haller H, Menne S, Ceral S, et al. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol. 2010; 56: 1254–1258.ScheffersIJKroonAASchmidliJJordanJTordoirJJMohauptMGLuftFCHallerHMenneSCeralSNovel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study20105612541258Search in Google Scholar
Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. Am Soc Hypertension. 2012; 6: 152–158.BakrisGLNadimMKHallerHLovettEGSchaferJEBisognanoJDBaroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial20126152158Search in Google Scholar
Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, Cates AW, Lovett EG, Haller H. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens. 2012; 6: 270–276.HoppeUCBrandtMCWachterRBeigeJRumpLCKroonAACatesAWLovettEGHallerHMinimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial20126270276Search in Google Scholar
Spiering W, Williams V, Van der Heyden J, van Kleef M, Lo R, Versmissen J, Moelker A, Kroon A, Reuter H, Ansel G, et al. Endovascular baroreflex amplification for resistant hypertension: A safety and proof-of-principle clinical study. Lancet. 2017; 390: 2655–2661SpieringWWilliamsVVan der HeydenJvan KleefMLoRVersmissenJMoelkerAKroonAReuterHAnselGEndovascular baroreflex amplification for resistant hypertension: A safety and proof-of-principle clinical study201739026552661Search in Google Scholar
Bates MC, Stone GW, Chen C-Y, Spiering W. Device profile on the MobiusHD EVBA system for the treatment of resistant hypertension: overview of its mechanism of action, safety and efficacy. Expert Rey Med Devices. 2020; 17: 649–665.BatesMCStoneGWChenC-YSpieringWDevice profile on the MobiusHD EVBA system for the treatment of resistant hypertension: overview of its mechanism of action, safety and efficacy202017649665Search in Google Scholar
Groenland EH, Spiering W. Baroreflex amplification and carotid body modulation for the treatment of resistant hypertension. Curr Hypertens Rep. 2020; 22: 27. doi: 10.1007/s11906-020-1024-xGroenlandEHSpieringWBaroreflex amplification and carotid body modulation for the treatment of resistant hypertension2020222710.1007/s11906-020-1024-xOpen DOISearch in Google Scholar
Van Kleef MEAM, Devireddy CM, van der Heyden J, Bates MC, Bakris GL, Stone GW, Williams B, Spiering W. CALM-FIM Investigators. Treatment of resistant hypertension with endovascular baroreflex amplification: 3 years of results from CALM-FIM study: JACC Cardiovascular results from CALM-FJM study. JACC Cardiovascular Intrev. 2022; 15: 321–332.Van KleefMEAMDevireddyCMvan der HeydenJBatesMCBakrisGLStoneGWWilliamsBSpieringWCALM-FIM InvestigatorsTreatment of resistant hypertension with endovascular baroreflex amplification: 3 years of results from CALM-FIM study: JACC Cardiovascular results from CALM-FJM study202215321332Search in Google Scholar
Halbach M, Grothaus D, Hoffmann F, Madershahian N, Kuhr K, Reuter H. Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension. Clin Auton Res. 2020; 30: 541–548.HalbachMGrothausDHoffmannFMadershahianNKuhrKReuterHBaroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension202030541548Search in Google Scholar
Walbach M, Koziolek M. Baroreceptors in the carotid and hypertension-systematic review and meta-analysis of the effects of baroreflex activation therapy on blood pressure. Nephrol Dial Transplant. 2018; 33: 1485–1493.WalbachMKoziolekMBaroreceptors in the carotid and hypertension-systematic review and meta-analysis of the effects of baroreflex activation therapy on blood pressure20183314851493Search in Google Scholar
Chunbin W, Fu S, Jing H. Efficacy and safety of baroreflex activation therapy for treatment of resistant hypertension: a systematic review and meta-analysis. Clin Exp Hypertens. 2018; 40: 501–508.ChunbinWFuSJingHEfficacy and safety of baroreflex activation therapy for treatment of resistant hypertension: a systematic review and meta-analysis201840501508Search in Google Scholar
Abraham WT, Zile MR, Weaver FA, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, Müller-Ehmsen J, Schafer JE et al. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction. JACC Heart Fail. 2015 Jun; 3: 487–496.AbrahamWTZileMRWeaverFAButterCDucharmeAHalbachMKlugDLovettEGMüller-EhmsenJSchaferJEBaroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction2015Jun3487496Search in Google Scholar
Coats AJS, Abraham WT, Zile MR, Lindenfeld JA, Weaver FA, Fudim M, Bauersachs J, Duval S, Galle E, Zannad F. Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials. Eur J Heart Fail. 2022; 24: 1665–1673.CoatsAJSAbrahamWTZileMRLindenfeldJAWeaverFAFudimMBauersachsJDuvalSGalleEZannadFBaroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials20222416651673Search in Google Scholar
Neuzil P, Merkely B, Erglis A, Marinskis G, de Groot JR, Schmidinger H, Rodriguez Venegas M, Voskuil M, Sturmberger T, et al. Pacemaker-mediated programmable hypertension control therapy. J Am Heart Assoc. 2017; 6: e006974. doi: 10.1161/JAHA.117.006974.NeuzilPMerkelyBErglisAMarinskisGde GrootJRSchmidingerHRodriguez VenegasMVoskuilMSturmbergerTPacemaker-mediated programmable hypertension control therapy20176e00697410.1161/JAHA.117.006974Open DOISearch in Google Scholar
Lauder L, Mahfoud F. Pacemaker-based cardiac neuromodulation therapy for the treatment of hypertension: the new kid on the block. J Am Heart Assoc. 2021; 10: e022622. doi: 10.1161/JAHA.121.022622LauderLMahfoudFPacemaker-based cardiac neuromodulation therapy for the treatment of hypertension: the new kid on the block202110e02262210.1161/JAHA.121.022622Open DOISearch in Google Scholar
Bazoukis G, Korantzopoulos P, Tsioufis C. The impact of renal sympathetic denervation on cardiac electrophysiology and arrhythmias: A systematic review of the literature. Int J Cardiol. 2016; 220: 87–101.BazoukisGKorantzopoulosPTsioufisCThe impact of renal sympathetic denervation on cardiac electrophysiology and arrhythmias: A systematic review of the literature201622087101Search in Google Scholar
Lian Z, Yu SR, Song JX, Lee CY, Li SF, Cui YX, Su LN, Chen H. Efficacy and safety of catheter-based renal denervation for heart failure with reduced ejection fraction: a systematic review and meta-analysis. Clin Auton Res. 2020; 30: 521–530.LianZYuSRSongJXLeeCYLiSFCuiYXSuLNChenHEfficacy and safety of catheter-based renal denervation for heart failure with reduced ejection fraction: a systematic review and meta-analysis202030521530Search in Google Scholar
Steinberg JS, Shabanov V, Ponomarev D, Losik D, Ivanickiy E, Kropotkin E, Polyakov K, Ptaszynski P, Keweloh B, Yao CJ, et al. Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: The ERADICATE-AF Randomized Clinical Trial. JAMA 2020; 21; 323: 248–255. doi: 10.1001/jama.2019.21187SteinbergJSShabanovVPonomarevDLosikDIvanickiyEKropotkinEPolyakovKPtaszynskiPKewelohBYaoCJEffect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: The ERADICATE-AF Randomized Clinical Trial20202132324825510.1001/jama.2019.21187Open DOISearch in Google Scholar
Kądziela J, Warchoł-Celińska E, Prejbisz A, Januszewicz A, Witkowski A, Tsioufis K. Renal denervation: can we press the “ON” button again in 2020? Postepy Kardiol Interwencyjnej. 2020 Sep; 16: 262–268. doi: 10.5114/aic.2020.99260. Epub 2020 Oct 2. PMID: 33597990KądzielaJWarchoł-CelińskaEPrejbiszAJanuszewiczAWitkowskiATsioufisKRenal denervation: can we press the “ON” button again in 2020?2020Sep1626226810.5114/aic.2020.99260Epub 2020 Oct 2.33597990Open DOISearch in Google Scholar
Nawar K, Mohammad A, Johns EJ, Abdulla MH. Renal denervation for arterial fibrillation: a comprehensive updated systematic review and meta-analysis. J Hum Hypertens. 2022; 36: 887–897.NawarKMohammadAJohnsEJAbdullaMHRenal denervation for arterial fibrillation: a comprehensive updated systematic review and meta-analysis202236887897Search in Google Scholar
Warchol-Celinska E, Prejbisz A, Kadziela J, Florczak E, Januszewicz A, Michalowska I, Dobrowolski P, Kabat M, et al. Renal denervation in resistant hypertension and obstructive sleep apnea: randomized proof-of concept Phase II trial. Hypertension. 2018; 72: 381–390.Warchol-CelinskaEPrejbiszAKadzielaJFlorczakEJanuszewiczAMichalowskaIDobrowolskiPKabatMRenal denervation in resistant hypertension and obstructive sleep apnea: randomized proof-of concept Phase II trial201872381390Search in Google Scholar